Same-day catheter removal after holmium laser enucleation of the prostate (HoLEP): a systematic review.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 10 07 2023
accepted: 22 09 2023
medline: 4 12 2023
pubmed: 25 10 2023
entrez: 25 10 2023
Statut: ppublish

Résumé

To summarize all existing evidence regarding the feasibility, safety, and efficacy of same-day trial of void and catheter removal after Holmium Laser Enucleation of the Prostate (HoLEP). Although there have been many reports of the safety and efficacy of same-day discharge from the hospital for selected patients undergoing HoLEP, in most of these reports, patients return to the hospital, usually on postoperative day one, to undergo a trial of void and catheter removal. PubMed®, Scopus®, and Cochrane® primary databases were systematically screened, from inception to 17 January 2023. The search strategy used the PICO (Patient, Intervention, Comparison, Outcomes) Framework. We followed the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Six studies met all the predefined criteria and were included in the final qualitative synthesis. Four studies were retrospective and two were prospective. Four studies were non-comparative, while two were comparative ones. The same-day catheter removal success rate ranged from 85.5 to 90% among studies, while only one grade-IIIb Clavien-Dindo complication was reported, which was unrelated to surgery. Same-day catheter removal is a feasible, safe, and efficient approach for selected patients undergoing HoLEP. Certain factors, such as intraoperative furosemide administration, were found to improve same-day catheter-free rates, while preoperative PVR and urinary retention were independent predictive factors of same-day trial of void failure.

Identifiants

pubmed: 37878061
doi: 10.1007/s00345-023-04655-x
pii: 10.1007/s00345-023-04655-x
doi:

Substances chimiques

Holmium W1XX32SQN1

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3503-3510

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Elmansy HM, Kotb A, Elhilali MM (2011) Holmium laser enucleation of the prostate: long-term durability of clinical outcomes and complication rates during 10 years of followup. J Urol 186(5):1972–1976. https://doi.org/10.1016/j.juro.2011.06.065 . (Epub 2011 Sep 23)
doi: 10.1016/j.juro.2011.06.065 pubmed: 21944127
Yin L, Teng J, Huang CJ, Zhang X, Xu D (2013) Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. J Endourol 27(5):604–611. https://doi.org/10.1089/end.2012.0505 . (Epub 2013 Feb 1)
doi: 10.1089/end.2012.0505 pubmed: 23167266
Parmar M, Katz JE, Blachman-Braun R, Smith NA, Oneto SM, Bhatia S, Kryvenko ON, Shah HN (2021) Safety and efficacy of holmium laser enucleation of prostate as salvage procedure for persistent or recurrent lower urinary tract symptoms secondary to bladder outlet obstruction after prior prostate artery embolization: a match analysis. World J Urol 39(11):4199–4206. https://doi.org/10.1007/s00345-021-03747-w . (Epub 2021 Jun 3)
doi: 10.1007/s00345-021-03747-w pubmed: 34081181
Marien T, Kadihasanoglu M, Tangpaitoon T, York N, Blackburne AT, Abdul-Muhsin H, Borofsky MS, Krambeck AE, Humphreys MR, Lingeman JE, Miller NL (2017) Outcomes of holmium laser enucleation of the prostate in the re-treatment setting. J Urol 197(6):1517–1522. https://doi.org/10.1016/j.juro.2016.12.098 . (Epub 2016 Dec 30)
doi: 10.1016/j.juro.2016.12.098 pubmed: 28043843
Abdul-Muhsin H, Critchlow W, Navaratnam A, Gnecco J, Tay K, Girardo M, Andrews P, Cheney S, Humphreys M (2020) Feasibility of holmium laser enucleation of the prostate as a 1-day surgery. World J Urol 38(4):1017–1025. https://doi.org/10.1007/s00345-019-02831-6 . (Epub 2019 Jun 13)
doi: 10.1007/s00345-019-02831-6 pubmed: 31197524
Assmus MA, Large T, Lee MS, Agarwal DK, Rivera ME, Krambeck AE (2021) Same-day discharge following holmium laser enucleation in patients assessed to have large gland prostates (≥175 cc). J Endourol 35(9):1386–1392. https://doi.org/10.1089/end.2020.1218 . (Epub 2021 Mar 17)
doi: 10.1089/end.2020.1218 pubmed: 33567989
Lwin AA, Zeng J, Evans P, Phung MC, Hynes KA, Price ET, Twiss CO, Tzou DT, Funk JT (2020) Holmium laser enucleation of the prostate is safe and feasible as a same day surgery. Urology 138:119–124. https://doi.org/10.1016/j.urology.2020.01.014 . (Epub 2020 Jan 18)
doi: 10.1016/j.urology.2020.01.014 pubmed: 31962119
Agarwal DK, Large T, Tong Y, Stoughton CL, Damler EM, Nottingham CU, Rivera ME, Krambeck AE (2022) Same day discharge is a successful approach for the majority of patients undergoing holmium laser enucleation of the prostate. Eur Urol Focus 8(1):228–234. https://doi.org/10.1016/j.euf.2020.12.018 . (Epub 2021 Jan 4)
doi: 10.1016/j.euf.2020.12.018 pubmed: 33414073
Klein C, Marquette T, Comat V, Alezra E, Capon G, Bladou F, Ferriere JM, Bensadoun H, Bernhard JC, Robert G (2021) Evolution of day-case holmium laser enucleation of the prostate success rate over time. J Endourol 35(3):342–348. https://doi.org/10.1089/end.2020.0337 . (Epub 2021 Jan 21)
doi: 10.1089/end.2020.0337 pubmed: 32935563
Salciccia S, Del Giudice F, Maggi M, Eisenberg ML, Chung BI, Conti SL, Kasman AM, Vilson FL, Ferro M, Lucarelli G, Viscuso P, Di Pierro G, Busetto GM, Luzi M, Sperduti I, Ricciuti GP, De Berardinis E, Sciarra A (2021) Safety and feasibility of outpatient surgery in benign prostatic hyperplasia: a systematic review and meta-analysis. J Endourol 35(4):395–408. https://doi.org/10.1089/end.2020.0538 . (Epub 2021 Mar 4)
doi: 10.1089/end.2020.0538 pubmed: 33081521
Agarwal DK, Rivera ME, Nottingham CU, Large T, Krambeck AE (2020) Catheter removal on the same day of holmium laser enucleation of the prostate: outcomes of a pilot study. Urology 146:225–229. https://doi.org/10.1016/j.urology.2020.09.038 . (Epub 2020 Oct 10)
doi: 10.1016/j.urology.2020.09.038 pubmed: 33045290
Noureldin Y, Gupta A, Hodhod A, Zakaria AS, Hadi RA, Mehrnoush V, Abbas L, Fathy M, Alaref A, Kotb A, Shahrour W, Elmansy H (2023) Same-day trial of void and discharge following standard vs MOSESTM holmium laser enucleation of the prostate: A single-center experience. Can Urol Assoc J 17(1):E23–E28. https://doi.org/10.5489/cuaj.7983
doi: 10.5489/cuaj.7983 pubmed: 36121886
Cooley LF, Assmus M, Ganesh M, Lee M, Helon J, Krambeck AE (2022) Predictors of failed same-day catheter removal after holmium laser enucleation of the prostate. Urology 170:168–173. https://doi.org/10.1016/j.urology.2022.07.047 . (Epub 2022 Aug 10)
doi: 10.1016/j.urology.2022.07.047 pubmed: 35963396
Narang G, Pougnier C, Wymer K, Chavez A, Mi L, Humphreys M, Cheney S (2023) Neuromuscular paralysis is not a barrier to same day catheter removal after HoLEP. Urology 171:179–183. https://doi.org/10.1016/j.urology.2022.10.020 . (Epub 2022 Nov 16)
doi: 10.1016/j.urology.2022.10.020 pubmed: 36400271
Slade A, Agarwal D, Large T, Sahm E, Schmidt J, Rivera M (2022) Expanded criteria same day catheter removal after holmium laser enucleation of the prostate. J Endourol 36(7):977–981. https://doi.org/10.1089/end.2022.0007 . (Epub 2022 Jun 21)
doi: 10.1089/end.2022.0007 pubmed: 35045752
Assmus MA, Lee MS, Helon JW, Krambeck AE (2022) Tranexamic acid does not improve outcomes of holmium laser enucleation of the prostate: A prospective randomized controlled trial. J Endourol. https://doi.org/10.1089/end.2022.0407 (Epub ahead of print)
Ramadhani MZ, Kloping YP, Rahman IA, Yogiswara N, Renaldo J, Wirjopranoto S (2022) Comparative efficacy and safety of holmium laser enucleation of the prostate (HoLEP) using moses technology and standard HoLEP: a systematic review, meta-analysis, and meta-regression. Ann Med Surg (Lond) 81:104280. https://doi.org/10.1016/j.amsu.2022.104280
doi: 10.1016/j.amsu.2022.104280 pubmed: 36147079
Khan A (2014) Day care monopolar transurethral resection of prostate: Is it feasible? Urol Ann 6(4):334–339. https://doi.org/10.4103/0974-7796.140998
doi: 10.4103/0974-7796.140998 pubmed: 25371612 pmcid: 4216541
Elmansy H, Shabana W, Ahmad A, Hodhod A, Hadi RA, Tablowski T, Zakaria AS, Fathy M, Labib F, Kotb A, Shahrour W (2022) Factors predicting successful same-day trial of void (TOV) after laser vaporization of the prostate. Urology 165:280–284. https://doi.org/10.1016/j.urology.2022.01.040 . (Epub 2022 Feb 12)
doi: 10.1016/j.urology.2022.01.040 pubmed: 35167883

Auteurs

Theodoros Spinos (T)

Department of Urology, University of Patras Hospital, 26504, Patras, Greece.

Vasileios Tatanis (V)

Department of Urology, University of Patras Hospital, 26504, Patras, Greece.

Evangelos Liatsikos (E)

Department of Urology, University of Patras Hospital, 26504, Patras, Greece.
Department of Urology, Medical University of Vienna, 1090, Vienna, Austria.

Panagiotis Kallidonis (P)

Department of Urology, University of Patras Hospital, 26504, Patras, Greece. pkallidonis@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH